Here are relevant reports on : prefilled-syringes-market
-
Dental Anesthetics Market by Drug Type (Lidocaine, Mepivacaine, Articaine, Bupivacaine, Mepivacaine, Prilocaine), Route of Administration (Topical, Injectable, Syringes, Needles), End User (Hospitals, Clinics, Others), Region - Global Forecast to 2030
The global dental anesthetics market, valued at US$1.43 billion in 2024, stood at US$1.48 billion in 2025 and is projected to advance at a resilient CAGR of 4.0% from 2025 to 2030, culminating in a forecasted valuation of US$1.80 billion by the end of the period. Several factors are driving the global market for dental anesthetics
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Medical Elastomer Market by Type (Thermoset Elastomers; Thermoplastic Elastomers), Applications (Medical Tubing; Catheters; Syringes; Gloves; Medical & Infusion Bags and Implants), End-use Industry & Region - Global Forecast to 2029
The medical elastomer market is expected to grow from USD 9.57 billion in 2024 to USD 14.27 billion by 2029, at a CAGR of 8.3% during the forecast period. The key global players in the medical elastomer market include BASF (Germany), Dow (US), Celanese Corporation (US), Eastman Chemical Company (US), Syensqo (Belgium), Mitsubishi Chemical Group Corporation (Japan), Kuraray Co., Ltd. (Japan), ExxonMobil (US), Momentive Performance Materials (US), Envalior (Germany) and Zeon Corporation (Japan).
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Enteral Feeding Devices Market By Type (Enteral Feeding Tubes, Nasogastric Tubes, Enteral Feeding Syringes, Nasal Feeding Tubes), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Hypermetabolism), End User - Global Forecast to 2032
The global enteral feeding devices market, valued at US$3.12 billion in 2024, stood at US$3.27 billion in 2025 and is projected to advance at a resilient CAGR of 5.5% from 2024 to 2032, culminating in a forecasted valuation of US$4.76 billion by the end of the period. Market growth is driven by the increasing geriatric population, technological advancements, regulatory support, greater awareness of nutritional needs, and expansion in emerging economies.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Blood Collection Devices Market by Product (Tubes (Plasma (EDTA, Heparin), Serum), Needles & Syringes, Blood Bags, Monitors), Method (Manual, Automated), Application (Diagnostics, Therapeutics), End User (Hospitals, Blood Banks) - Global Forecast to 2030
The global blood collection devices market, valued at US$8.61 billion in 2024, stood at US$9.13 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2024 to 2030, culminating in a forecasted valuation of US$13.02 billion by the end of the period. The growing number of accidents and trauma cases has further increased the need for rapid and reliable blood collection for diagnostics and emergency care.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Patient Blood Management Market by Product (Instrument (Centrifuge, Transfusion Device, Apheresis, PCR, NGS, Storage Device), Accessories (Syringes, Vials), Reagents, Software)), Component, End User (Blood Bank, Hospital) - Global Forecast to 2024
The global patient blood management market size is expected to grow USD 15.3 billion by 2024, at a CAGR of 7.4% during the forecasting period. The major players in the market include Haemonetics Corporation (US), Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Immucor, Inc. (US), B. Braun Melsungen AG (Ireland), Macopharma (US), bioMérieux SA (France), Asahi Kasei Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), Grifols, S.A. (Spain), F. Hoffmann-La Roche LTD (Switzerland), LivaNova PLC (UK), Danaher Corporation (US), Mediware Information Systems (US), Kawasumi Laboratories, Inc. (Japan), Haier Biomedical (China), Diatron (Hungary), and BAG Diagnostics GmbH (Germany), among others.
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029
The global pharmaceutical drug delivery market, valued at US$1,831.1 million in 2023, stood at US$1,949.4 million in 2024 and is projected to advance at a resilient CAGR of 5.5% from 2024 to 2029, culminating in a forecasted valuation of US$2,546.0 million by the end of the period. The increasing patient population with chronic diseases, coupled with the growing geriatric population, rising technological advancements in pharmaceutical drug delivery products offering enhanced patient convenience and compliance, the growing adoption of home-based and self-administration, rising government initiatives promoting accessibility to pharmaceutical drug delivery, and the increasing demand for biosimilars and biologics are likely to support market growth.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Human Insulin Market By Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications (Type 1 Diabetes, Type 2 Diabetes) - Global Forecast to 2020
The global human insulin market size is projected to grow at a CAGR of 8.1%. Market growth can be attributed to factors such as growing diabetes patient population, increasing population exposure to key risk factors leading to diabetes, rising market demand for human insulin analogs, technological advancements in the field of human insulin delivery devices, and favorable medical reimbursements. However, stringent regulatory requirements for product approval are restraining the growth of this market.
- Published: December 2015
- Price: $ 4950
- TOC Available:
-
Insulin Delivery Device Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Pen Needle (Standard, Safety), Insulin Syringes, Others), Disease Type (Type 1 Diabetes, Type 2 Diabetes) - Global Forecast to 2030
The global insulin delivery devices market, valued at US$32.6 billion in 2024, stood at US$35.3 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2030, culminating in a forecasted valuation of US$ 52.7 billion by the end of the period. The insulin delivery devices market is experiencing steady growth, primarily due to the increasing number of individuals diagnosed with diabetes. The rising prevalence of type 1 diabetes, in particular, is driving the demand for insulin delivery devices, as patients with this condition rely on insulin to manage their blood glucose levels.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Aseptic Sampling Market by Type (Manual [Type (Traditional, Single-use), Product (Bags, Bottles, Syringes, Accessories)], Automatic), Application (Upstream, Downstream), Technique (Off-line, On-line), End User (R&D, CMO, CRO) - Global Forecast to 2025
The global aseptic sampling market is projected to reach USD 474 million by 2025 from USD 264 million in 2020, at a CAGR of 12.4%. Market growth is driven mainly by the increasing demand for biopharmaceuticals, stringent government regulations to ensure drug safety, and funding to support life sciences research activities.
- Published: June 2020
- Price: $ 4950
- TOC Available:
-
Urea Market by Grade (Agricultural, Technical, Feed, Medical), Product Type (Granular, Prilled), End-Use Industry (Agriculture, Chemical, Automotive, Medical), Application, Technology & Region - Global Forecast to 2029
The urea market is expected to grow from USD 80.25 billion in 2024 to USD 93.25 billion by 2029, at a CAGR of 3.05% during the forecast period. The urea market report comprises key manufacturers such as CF Industries Holdings, Inc. (US), Pupuk Indonesia (Persero) (Indonesia), Yara International ASA (Norway), SABIC (Saudi Arabia), OCI (Netherlands), Nutrien (Canada), EuroChem Group (Switzerland), Qatar Fertiliser Company (Qatar), BASF SE (Germany), CNPC (China), and IFFCO (India).
- Published: November 2024
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50